The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency.
Gu Y, Wang C, Zhu R, Yang J, Yuan W, Zhu Y, Zhou Y, Qin N, Shen H, Ma H, et al. Cancer Biol Med. 2021 Feb 15; 18(1):74-87.